Results 101 to 110 of about 189,515 (386)

Emollients and moisturisers for eczema.

Cochrane Database of Systematic Reviews, 2017
BACKGROUND Eczema is a chronic skin disease characterised by dry skin, intense itching, inflammatory skin lesions, and a considerable impact on quality of life.
E. V. van Zuuren, Z. Fedorowicz, R. Christensen, A. Lavrijsen, B. Arents   +4 more
semanticscholar   +1 more source

Aggressive Head and Neck Squamous Cell Carcinoma in the Setting of GATA2 Deficiency

Head &Neck, EarlyView.
ABSTRACT Background GATA2 deficiency is a rare genetic disorder associated with hematologic, infectious, and neoplastic complications. We report a case of a patient with GATA2 deficiency who developed aggressive squamous cell carcinoma (SCC) of the head and neck, an atypical manifestation of this condition.
Brejjette Aljabi, James A. Stewart, Kirk Withrow, Carissa M. Thomas   +3 more
wiley   +1 more source

Skin microbiome engineering: Challenges and opportunities in skin diseases treatment

iMetaOmics, EarlyView.
The skin microbiome plays a crucial role in skin health, influencing barrier integrity, immune responses, and disease susceptibility. Various interventions can reshape the microbiome, broadly categorized into targeted and untargeted approaches. Targeted strategies, such as phage therapy, engineered bacteria, and phage lysins, selectively modulate ...
Yiang Lyu, Juntao Shen, You Che, Lei Dai
wiley   +1 more source

Patient and caregiver motivators and barriers to eczema clinical trial participation: Analysis of survey data

Skin Health and Disease
Background Eczema clinical trials (CTs) are increasing in number, yet participation across the eczema community is low. Little is known about patient characteristics and views on motivators and barriers to CT participation (CTP).
Michael Evan Jacobson, Isabelle J. Thibau, Wenelia Baghoomian, Emile Latour, Ajai Kastala, Allison R. Loiselle, Eric Lawrence Simpson, Wendy Smith Begolka   +7 more
doaj   +1 more source

Development and initial testing of a new instrument to measure the experience of eczema control in adults and children: Recap of atopic eczema (RECAP)†

British Journal of Dermatology, 2019
Eczema control has been identified as an important outcome by key stakeholders in eczema research (including patients, carers, healthcare professionals and researchers) but no validated instruments for the domain have been identified.
L. Howells, Joanne R Chalmers, S. Gran, Amina Ahmed, C. Apfelbacher, C. Apfelbacher, T. Burton, L. Howie, Sandra Lawton, Matthew J Ridd, Natasha K. Rogers, A. V. Sears, P. Spuls, L. Kobyletzki, L. Kobyletzki, Kim S Thomas   +15 more
semanticscholar   +1 more source

Essential fatty acid deficiency, olive oil‐based intravenous lipid emulsion, and genetic polymorphisms: A pediatric randomized controlled trial

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives There is a concern that decreasing soybean oil (SO) content in intravenous lipid emulsions (ILEs) may increase the risk for essential fatty acid deficiency (EFAD). This study evaluates the risk of EFAD in pediatric patients who were expected to require parenteral nutrition for at least 7 days with an 80% olive oil/20% SO ILE (OO/SO ...
Cynthia Blanco, Weili Chang, Abhay J. Bhatt, Erick Gerday, Ajay J. Talati, Narendra Dereddy, Rachana Singh, Erika Ryan, Thibault Senterre   +8 more
wiley   +1 more source

Effect of dupilumab on hand eczema in patients with atopic dermatitis: An observational study

Journal of dermatology (Print), 2019
Systemic treatment options for chronic hand eczema are limited. Dupilumab is used in atopic dermatitis (AD) but is not licensed for (isolated) hand eczema.
J. Oosterhaven, A. Voorberg, G. Romeijn, M. D. de Bruin‐Weller, M. Schuttelaar   +4 more
semanticscholar   +1 more source

Genital Crohn's disease in pediatrics and genetic associations

JPGN Reports, EarlyView.
Abstract Genital edema is a rare presentation of Crohn's disease (CD), also known as metastatic CD (MCD). This may precede, co‐occur with, or follow gastrointestinal symptoms and present a diagnostic challenge. We aimed to characterize the features, clinical courses, pathogenesis, and outcomes of patients with MCD to increase understanding and promote ...
Erica Chang, Caroline Chinchilla Putzeys, Edward Hoffenberg, Ashish Patel, Elizabeth Hilow, Brad Pasternak   +5 more
wiley   +1 more source

TREatment of ATopic eczema (TREAT) Registry Taskforce: consensus on how and when to measure the core dataset for atopic eczema treatment research registries. [PDF]

, 2019
BackgroundComparative, real-life and long-term evidence on the effectiveness and safety of phototherapy and systemic therapy in moderate-to-severe atopic eczema (AE) is limited.
Apfelbacher, CJ, Arents, BWM, Barbarot, S, Bosma, AL, Deleuran, M, Eichenfield, LF, Flohr, C, Gerbens, LAA, International TREAT Registry Taskforce, Irvine, AD, Manca, A, Middelkamp-Hup, MA, Schmitt, J, Spuls, PI, Vermeulen, FM, Vestergaard, C, Wall, D, Weidinger, S   +17 more
core  

Pollen grains induce a rapid and biphasic eczematous immune response in atopic eczema patients [PDF]

, 2008
Introduction: Eczematous reactions to type I allergy-inducing antigens are documented in a subgroup of patients with atopic eczema. Yet, the underlying immunological mechanisms are not well understood.
Behrendt, Heidrun, Darsow, Ulf, Eyerich, Kilian, Foerster, Stefanie, Huss-Marp, Johannes, Ring, Johannes, Traidl-Hoffmann, Claudia, Wollenberg, Andreas   +7 more
core   +2 more sources